Topics

Janssen's Imbruvica Leads CLL Market Expansion In Europe

08:45 EDT 15 Aug 2019 | SCRIP

Imbruvica is keeping ahead of potential competitors in Europe by expanding its use in patients with chronic lymphocytic leukemia and...

      

Related Stories

 

Original Article: Janssen's Imbruvica Leads CLL Market Expansion In Europe

NEXT ARTICLE

More From BioPortfolio on "Janssen's Imbruvica Leads CLL Market Expansion In Europe"

Quick Search